Rodgers Brothers’s Pfizer PFE Stock Holding History

Rodgers Brothers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$945K	Sell	33,646 -95	-0.3%	-$2.53K	0.11%	141
2025 Q4	$840K	Sell	33,741 -554	-2%	-$14K	0.1%	146
2025 Q3	$874K	Sell	34,295 -1,042	-3%	-$25.7K	0.11%	143
2025 Q2	$857K	Sell	35,337 -2,946	-8%	-$68.7K	0.11%	144
2025 Q1	$970K	Sell	38,283 -20	-0.1%	-$523	0.13%	133
2024 Q4	$1.02M	Sell	38,303 -1,075	-3%	-$29.2K	0.13%	129
2024 Q3	$1.14M	Sell	39,378 -245	-0.6%	-$7.15K	0.14%	124
2024 Q2	$1.11M	Sell	39,623 -470	-1%	-$12.9K	0.15%	127
2024 Q1	$1.11M	Sell	40,093 -594	-1%	-$16.5K	0.15%	127
2023 Q4	$1.17M	Sell	40,687 -34,016	-46%	-$1.03M	0.18%	109
2023 Q3	$2.48M	Buy	74,703 +7,054	+10%	+$249K	0.42%	65
2023 Q2	$2.48M	Buy	67,649 +1,365	+2%	+$53.1K	0.44%	65
2023 Q1	$2.7M	Buy	66,284 +1,000	+2%	+$43.2K	0.52%	57
2022 Q4	$3.35M	Sell	65,284 -5,050	-7%	-$242K	0.67%	51
2022 Q3	$3.08M	Sell	70,334 -449	-0.6%	-$21.8K	0.66%	48
2022 Q2	$3.71M	Buy	70,783 +38,950	+122%	+$1.98M	0.73%	43
2022 Q1	$1.65M	Sell	31,833 -1,124	-3%	-$58.3K	0.3%	82
2021 Q4	$1.95M	Hold	32,957	–	–	0.35%	72
2021 Q3	$1.42M	Sell	32,957 -54,909	-62%	-$2.43M	0.28%	89
2021 Q2	$3.44M	Buy	87,866 +30,248	+52%	+$1.18M	0.66%	43
2021 Q1	$2.09M	Buy	57,618 +3,000	+5%	+$107K	0.43%	65
2020 Q4	$2.01M	Sell	54,618 -3,348	-6%	-$123K	0.46%	64
2020 Q3	$2.02M	Sell	57,966 -211	-0.4%	-$7.4K	0.52%	54
2020 Q2	$1.8M	Buy	58,177 +1,351	+2%	+$45.9K	0.49%	52
2020 Q1	$1.76M	Buy	56,826 +1,061	+2%	+$36.2K	0.56%	45
2019 Q4	$2.07M	Sell	55,765 -2,979	-5%	-$106K	0.54%	52
2019 Q3	$2M	Buy	58,744 +1,167	+2%	+$42.4K	0.55%	50
2019 Q2	$2.37M	Buy	57,577 +8,548	+17%	+$339K	0.66%	43
2019 Q1	$1.98M	Buy	49,029 +11,436	+30%	+$458K	0.56%	51
2018 Q4	$1.56M	Sell	37,593 -7,061	-16%	-$293K	0.5%	54
2018 Q3	$1.87M	Sell	44,654 -17,270	-28%	-$665K	0.54%	50
2018 Q2	$2.13M	Buy	61,924 +5,515	+10%	+$188K	0.65%	46
2018 Q1	$1.9M	Buy	56,409 +4,473	+9%	+$154K	0.62%	50
2017 Q4	$1.78M	Buy	51,936 +12	+0%	+$409	0.58%	50
2017 Q3	$1.76M	Buy	51,924 +856	+2%	+$27.5K	0.62%	47
2017 Q2	$1.63M	Buy	51,068 +4,348	+9%	+$137K	0.6%	48
2017 Q1	$1.52M	Buy	46,720 +958	+2%	+$30.2K	0.57%	49
2016 Q4	$1.41M	Sell	45,762 -884	-2%	-$27K	0.55%	51
2016 Q3	$1.5M	Buy	46,646 +8	+0%	+$267	0.6%	48
2016 Q2	$1.56M	Buy	46,638 +1,480	+3%	+$47.2K	0.64%	46
2016 Q1	$1.27M	Buy	45,158 +3,985	+10%	+$114K	0.55%	48
2015 Q4	$1.26M	Sell	41,173 -2,510	-6%	-$79K	0.59%	47
2015 Q3	$1.3M	Buy	43,683 +4,163	+11%	+$133K	0.65%	43
2015 Q2	$1.26M	Hold	39,520	–	–	0.59%	50
2015 Q1	$1.3M	Sell	39,520 -884	-2%	-$28.1K	0.64%	46
2014 Q4	$1.19M	Buy	40,404 +988	+3%	+$28.3K	0.6%	49
2014 Q3	$1.11M	Hold	39,416	–	–	0.58%	47
2014 Q2	$1.11M	Buy	39,416 +105	+0.3%	+$2.99K	0.55%	50
2014 Q1	$1.2M	Buy	39,311 +1,370	+4%	+$40.8K	0.58%	46
2013 Q4	$1.1M	Hold	37,941	–	–	0.55%	50
2013 Q3	$1.03M	Buy	37,941 +3,083	+9%	+$83.9K	0.57%	51
2013 Q2	$926K	Buy	+34,858	New	+$963K	0.55%	51

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Rodgers Brothers's PFE Position: Q1 2026 in Review

Rodgers Brothers reduced its Pfizer (PFE) stake by 0.28% in Q1 2026, selling an estimated $2.53K and leaving 33,646 shares worth $945K. The position accounts for 0.11% of the portfolio, ranked #141.

Rodgers Brothers first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.71M in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Rodgers Brothers held 33,646 shares of Pfizer worth $945K as of Q1 2026.
Rodgers Brothers sold 95 Pfizer shares in Q1 2026, an estimated $2.53K.
Pfizer made up 0.11% of Rodgers Brothers's portfolio in Q1 2026, its #141 holding.
Rodgers Brothers first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Rodgers Brothers's Pfizer position peaked at $3.71M in Q2 2022.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.